-
Drugmakers in India — the world’s largest supplier of non-patented medicines — aim to tap what could be a $94 billion global opportunity by 2035
-
Ozempic has, in the recent times, become popular for weight loss, but new research hints it may hamper muscle strength, even if size stays the same. The results, from a mouse study, spark calls for human trials, especially for older adults vulnerable to weakness.
-
Cricketer Sarfaraz Khan’s stunning weight loss has sparked a wave of interest in Green coffee. With the public increasingly curious about natural alternatives to weight loss medications, his story is drawing attention to this modest, unroasted bean and its potential role in supporting healthy living without synthetic drugs
-
Men using the weight-loss drug claim to be experiencing 'Ozempic penis' phenomenon, sparking debate on online forums.
-
Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.
-
Is Ozempic good for you? A nutritionist advises caution while using weight loss drugs. Here's what to keep in mind
-
Novo and Lilly’s campaigns are not limited to advertisements alone, and both companies are trying to raise awareness around obesity through research studies and conferences.
-
With rumours circulating that Selena Gomez and other celebrities have used Ozempic, we reached out to experts to understand its benefits and whether it’s a one-stop solution for weight loss and diabetes management.
-
The first order impact will be a slow market share gain from innovators after a generic launch
-
Global sales from these drugs in Q3 CY2024 were a staggering $11.2 billion. Street estimates for GLP 1 drugs sales for anti-diabetic and/or obesity control are upwards of $150 billion in 2030.
-
Ozempic is a medicine that helps control type 2 diabetes by helping your body regulate blood sugar levels better. Here are its best ways to take and side effects of Ozempic.
-
From EU regulator probing Apple, Canada mulling tariffs on China-made EVs to Nvidia stock tumbling 6 percent and Shein exploring a London listing , here's a look at recent business developments around the world.
-
The success of Novo Nordisk -- makers of Ozempic and Wegovy, shows the outsized effect a single company can have on a nation
-
Discussions and focus on health topics are rife today, a day after World Cancer Day. On that note, Ozempic, originally designed to tackle Type 2 diabetes, caused a stir as the latest weight loss craze in Tinseltown
-
Earlier this year, Oprah Winfrey had joined the conversation around Ozempic, a Type 2 diabetes drug that leads to weight-loss too, saying using the drug would be 'the easy way out'.
-
Investors fear the rise of weight-loss drugs eating into their profits. But companies from Nestle to PepsiCo aren’t panicking yet
-
Companies from Walmart Inc. to Conagra Brands Inc. are weighing how much to factor the diabetes drugs known as GLP-1s, increasingly being used for weight loss, into their strategies.
-
Texas professor Maria Rosas wrote a piece for Newsweek about her experience with Ozempic, saying the drug left her with burnt genitals and charred skin.
-
GLP1 drugs are poised to reshape the weight-loss market and US waistlines. There are implications for booze companies, too
-
Some anesthesiologists in the US and Canada say they've seen growing numbers of patients on the weight-loss drugs who inhaled food and liquid into their lungs while sedated because their stomachs were still full even after following standard instructions to stop eating for six to eight hours in advance.
-
Research published Sunday evaluates the effectiveness of the active ingredient in injectable diabetes and obesity drugs when taken orally.
-
Ozempic is a brand name for the generic drug semaglutide, which is FDA-approved to treat Type-2 Diabetes by controlling blood sugar levels.
